# Avid Radiopharmaceuticals clinical trials: 54 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 54 trials with Avid Radiopharmaceuticals as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Avid Radiopharmaceuticals: 54 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/avid-radiopharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 54
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 54, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| March 20, 2023 | NCT05775601 | 18F-LY3950321-01 Biodistribution and Safety Study | Avid Radiopharmaceuticals | Early phase 1 | Completed | Diagnostic Agent Adverse Reaction, Radiation Exposure | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05775601) |
| January 25, 2021 | NCT04721756 | Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging | Avid Radiopharmaceuticals | Early phase 1 | Unknown | Neoplasms, Neoplasms Malignant | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04721756) |
| July 16, 2020 | NCT04474405 | Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects | Avid Radiopharmaceuticals | Early phase 1 | Completed | Alzheimer Disease | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04474405) |
| July 13, 2020 | NCT04468347 | Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease | Avid Radiopharmaceuticals | Phase 1 | Completed | Alzheimer Disease, Mild Cognitive Impairment | 89 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04468347) |
| April 3, 2019 | NCT03901105 | Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease | Avid Radiopharmaceuticals | Phase 3 | Completed | Alzheimer Disease | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03901105) |
| April 3, 2019 | NCT03901092 | A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation | Avid Radiopharmaceuticals | Phase 3 | Completed | Alzheimer Disease | 242 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03901092) |
| March 16, 2018 | NCT03467477 | Tau Screening Study in Subjects With Early Symptomatic AD | Avid Radiopharmaceuticals | Phase 2 | Completed | Alzheimer Disease | 161 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03467477) |
| October 26, 2017 | NCT03322462 | Tau Screening Study in Patients With Early Symptomatic AD | Avid Radiopharmaceuticals | Phase 2 | Completed | Alzheimer Disease | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03322462) |
| February 14, 2017 | NCT03052972 | Flortaucipir 18F PET Imaging in BIOCARD Study | Avid Radiopharmaceuticals | Phase 1 | Terminated | Cognitive Decline | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03052972) |
| February 2, 2017 | NCT03040713 | Flortaucipir PET Imaging in Subjects With FTD | Avid Radiopharmaceuticals | Phase 1 | Completed | Frontotemporal Dementia | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03040713) |
| September 29, 2016 | NCT02918539 | Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials | Avid Radiopharmaceuticals | Observational | Completed | Alzheimer Disease, Cognition Disorders | 317 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02918539) |
| June 10, 2016 | NCT02795780 | Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05 | Avid Radiopharmaceuticals | Phase 2 | Completed | Alzheimer's Disease | 79 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02795780) |
| August 5, 2015 | NCT02516046 | 18F-AV-1451 Autopsy Study | Avid Radiopharmaceuticals | Phase 3 | Completed | Alzheimer's Disease | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02516046) |
| July 30, 2015 | NCT02512029 | 18F-AV-1451 PET Imaging in TBI | Avid Radiopharmaceuticals | Phase 1 | Withdrawn | Traumatic Brain Injury | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02512029) |
| January 30, 2015 | NCT02350634 | 18F-AV-1451 High Resolution Autopsy Study | Avid Radiopharmaceuticals | Phase 1 | Completed | Alzheimer's Disease | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02350634) |
| January 13, 2015 | NCT02336360 | Augmenting Flortaucipir Dosimetry Estimates | Avid Radiopharmaceuticals | Phase 1 | Completed | Alzheimer's Disease | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02336360) |
| October 30, 2014 | NCT02278367 | Clinical Evaluation of Flortaucipir F 18 | Avid Radiopharmaceuticals | Phase 2 | Completed | Alzheimer's Disease, Traumatic Brain Injury, Depression | 179 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02278367) |
| October 30, 2014 | NCT02278354 | Tau Imaging in Professional Fighters | Avid Radiopharmaceuticals | Phase 1 | Completed | Alzheimer's Disease | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02278354) |
| June 19, 2014 | NCT02167594 | Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers | Avid Radiopharmaceuticals | Phase 1 | Completed | Progressive Supranuclear Palsy, Corticobasal Degeneration | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02167594) |
| April 23, 2014 | NCT02120664 | Florbetapir Calibration to the Centiloid Scale | Avid Radiopharmaceuticals | Phase 1 | Completed | Alzheimer's Disease | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02120664) |
| April 8, 2014 | NCT02107599 | The Feasibility of Florbetapir Quantitation in Europe | Avid Radiopharmaceuticals | Phase 4 | Completed | Alzheimer's Disease | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02107599) |
| March 6, 2014 | NCT02079766 | 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy | Avid Radiopharmaceuticals | Phase 2 | Completed | Chronic Traumatic Encephalopathy | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02079766) |
| January 31, 2014 | NCT02051790 | Evaluation of Reader Training Processes | Avid Radiopharmaceuticals | Phase 4 | Completed | Alzheimer's Disease | 241 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02051790) |
| January 31, 2014 | NCT02051764 | Imaging Characteristics of a Follow-up 18F-AV-1451 Scan | Avid Radiopharmaceuticals | Phase 2 | Terminated | Alzheimer's Disease | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02051764) |
| January 8, 2014 | NCT02029547 | Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians | Avid Radiopharmaceuticals | Not applicable | Withdrawn | Alzheimer's Disease | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02029547) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 6 |
| Phase 1 | 16 |
| Phase 1/2 | 1 |
| Phase 2 | 12 |
| Phase 2/3 | 3 |
| Phase 3 | 7 |
| Phase 4 | 4 |
| Not applicable | 4 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 46 |
| Terminated | 5 |
| Withdrawn | 2 |
| Unknown | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Alzheimer Disease | 42 |
| Cognitive Dysfunction | 8 |
| Parkinson Disease | 3 |
| Frontotemporal Dementia | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Neurodegenerative Diseases | 2 |
| Brain Injuries, Traumatic | 2 |
| Diabetes Mellitus, Type 1 | 1 |
| Chronic Traumatic Encephalopathy | 1 |
| Supranuclear Palsy, Progressive | 1 |
| Corticobasal Degeneration | 1 |
| Cognition Disorders | 1 |
| Lewy Body Disease | 1 |
| Depression | 1 |
| Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Assisted living facilities in the United States](https://specstream.ai/data/businesses/assisted-living-facilities/united-states)
- [Cheesesteak restaurants in the United States](https://specstream.ai/data/businesses/cheesesteak-restaurants/united-states)
- [Entertainment law firms in the United States](https://specstream.ai/data/businesses/entertainment-law-firms/united-states)
- [Hydro jetting companies in the United States](https://specstream.ai/data/businesses/hydro-jetting-companies/united-states)
- [Music schools in the United States](https://specstream.ai/data/businesses/music-schools/united-states)
- [Ramen restaurants in the United States](https://specstream.ai/data/businesses/ramen-restaurants/united-states)
